» Authors » M Buchler

M Buchler

Explore the profile of M Buchler including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 314
Citations 4868
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kempeneers M, Issa Y, Ali U, Baron R, Besselink M, Buchler M, et al.
Pancreatology . 2019 Dec; 20(2):149-157. PMID: 31870802
Background/objectives: Chronic pancreatitis (CP) is a complex inflammatory disease with pain as the predominant symptom. Pain relief can be achieved using invasive interventions such as endoscopy and surgery. This paper...
2.
Gaiffe E, Crepin T, Bamoulid J, Courivaud C, Buchler M, Cassuto E, et al.
Trials . 2019 Jun; 20(1):375. PMID: 31227028
Background: Post-transplant diabetes is a frequent and serious complication of kidney transplantation. There is currently no treatment to prevent or delay the disease. Nevertheless, identification of risk factors make it...
3.
Encatassamy F, Valentin A, Capsec J, Buchler M, Bruyere F
Prog Urol . 2018 Feb; 28(6):322-328. PMID: 29395835
Introduction: Bacterial colonization of preservative solutions (PS) remains poorly described in renal transplantation. We investigated the bacterial colonization of the PS and its influence on graft pyelonephritis within one year...
4.
Bruyere F, Pradere B, Faivre dArcier B, Boutin J, Buchler M, Brichart N
Prog Urol . 2017 Nov; 28(1):48-54. PMID: 29158031
Objectives: To describe the technique and report our first experience of robotic-assisted renal transplantation (RART) with more than one year follow up. Patients And Methods: In our center the first...
5.
Gatault P, Kamar N, Buchler M, Colosio C, Bertrand D, Durrbach A, et al.
Am J Transplant . 2016 Nov; 17(5):1370-1379. PMID: 27862923
The aim of this study (ClinicalTrials.gov, NCT01744470) was to determine the efficacy and safety of two different doses of extended-release tacrolimus (TacER) in kidney transplant recipients (KTRs) between 4 and...
6.
Damon C, Luck M, Toullec L, Etienne I, Buchler M, Hurault de Ligny B, et al.
Am J Transplant . 2016 Sep; 17(4):1008-1019. PMID: 27597269
Any biochemical reaction underlying drug metabolism depends on individual gene-drug interactions and on groups of genes interacting together. Based on a high-throughput genetic approach, we sought to identify a set...
7.
Pallet N, Etienne I, Buchler M, Bailly E, Hurault de Ligny B, Choukroun G, et al.
Am J Transplant . 2016 Mar; 16(9):2670-5. PMID: 26990694
Pretransplantation adaptation of the daily dose of tacrolimus to CYP3A5 genotype is associated with improved achievement of target trough concentration (C0 ), but whether this improvement affects clinical outcomes is...
8.
Encatassamy F, Valentin A, Buchler M, Bruyere F
Prog Urol . 2015 Nov; 25(13):763-4. PMID: 26544293
No abstract available.
9.
Pallet N, Jannot A, El Bahri M, Etienne I, Buchler M, de Ligny B, et al.
Am J Transplant . 2015 Jan; 15(3):800-5. PMID: 25588704
CYP3A4*22 is an allelic variant of the cytochrome P450 3A4 associated with a decreased activity. Carriers of this polymorphism may require reduced tacrolimus (Tac) doses to reach the target residual...
10.
Thierry A, Mourad G, Buchler M, Choukroun G, Toupance O, Kamar N, et al.
J Transplant . 2014 May; 2014:171898. PMID: 24829794
In a six-month, multicenter, open-label trial, de novo kidney transplant recipients at low immunological risk were randomized to steroid avoidance or steroid withdrawal with IL-2 receptor antibody (IL-2RA) induction, enteric-coated...